Active Learning with Support Vector Machines in the Drug Discovery Process
Top Cited Papers
- 12 February 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Computer Sciences
- Vol. 43 (2) , 667-673
- https://doi.org/10.1021/ci025620t
Abstract
We investigate the following data mining problem from computer-aided drug design: From a large collection of compounds, find those that bind to a target molecule in as few iterations of biochemical testing as possible. In each iteration a comparatively small batch of compounds is screened for binding activity toward this target. We employed the so-called “active learning paradigm” from Machine Learning for selecting the successive batches. Our main selection strategy is based on the maximum margin hyperplanegenerated by “Support Vector Machines”. This hyperplane separates the current set of active from the inactive compounds and has the largest possible distance from any labeled compound. We perform a thorough comparative study of various other selection strategies on data sets provided by DuPont Pharmaceuticals and show that the strategies based on the maximum margin hyperplane clearly outperform the simpler ones.Keywords
This publication has 5 references indexed in Scilit:
- A Novel Shape-Feature Based Approach to Virtual Library ScreeningJournal of Chemical Information and Computer Sciences, 2002
- Coupling structure-based design with combinatorial chemistry: application of active site derived pharmacophores with informative library designJournal of Molecular Graphics and Modelling, 2002
- Sparse Regression Ensembles in Infinite and Finite Hypothesis SpacesMachine Learning, 2002
- Drug design by machine learning: support vector machines for pharmaceutical data analysisComputers & Chemistry, 2001
- The Nature of Statistical Learning TheoryPublished by Springer Nature ,1995